URGN,UroGen Pharma Ltd. | Healthcare

Healthcare

URGN

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

UroGen Pharma Ltd.URGN

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases.

It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution.

The company's lead product candidate is UGN-102 for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial carcinoma and low-grade non-muscle invasive bladder cancer.

It is also developing UGN-301 for the treatment of high-grade non-muscle invasive bladder cancer. Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; and strategic research collaboration with MD Anderson to advance investigational treatment for NMIBC.

UroGen Pharma Ltd. was incorporated in 2004 and is based in Princeton, New Jersey.

Latest News >

Standex International Insider Sold Shares Worth $584,405, According to a Recent SEC Filing

Aug 7, 2025

02:18 PM EDT, 08/07/2025 (MT Newswires) -- Ademir Sarcevic, Vice President, CFO, Treasurer, on August 06, 2025, sold 3,047 shares in Standex International ( SXI ) for $584,405. Following the Form 4 filing with the SEC, Sarcevic has control over a total of 11,323 common shares of the company, with 11,323 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/310354/000112760225020214/xslF345X05/form4.xml Price: 192.19, Change:...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

A O Smith Insider Sold Shares Worth $1,241,953, According to a Recent SEC Filing

Aug 7, 2025

02:20 PM EDT, 08/07/2025 (MT Newswires) -- James F Stern, Executive Vice President, General Counsel & Secretary, on August 07, 2025, sold 17,434 shares in A O Smith ( AOS ) for $1,241,953. Following the Form 4 filing with the SEC, Stern has control over a total of 98,784 common shares of the company, with 98,784 shares held directly. SEC...

Sunrun Shares Rise After Q2 Net Income, Revenue Beat Expectations

Aug 7, 2025

02:19 PM EDT, 08/07/2025 (MT Newswires) -- Sunrun ( RUN ) shares were up more than 29% in recent Thursday trading after the company reported late Wednesday Q2 earnings and revenue that increased year-over-year and beat analyst expectations. The energy service company reported Q2 net income of $1.07 per diluted share, up from $0.55 a year earlier. Analysts polled by...